# Axi-cel Retreatment in Relapsed/Refractory LBCL

> **NCT05800067** · NA · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 32 (estimated)

## Conditions studied

- CAR-T Retreatment

## Interventions

- **DRUG:** axi-cel

## Key facts

- **NCT ID:** NCT05800067
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-04
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05800067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05800067, "Axi-cel Retreatment in Relapsed/Refractory LBCL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05800067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*